Clinical Trials Browser

INDUSTRY × tositumomab I-131 × Clear all

NCT00992992 2019-12-04

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

Phase 2 Completed

25 enrolled 23 charts

Lymphoma, Mantle-Cell

NCT01536561 2017-08-31

Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma

Phase 1 Completed

59 enrolled 27 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT00992758 2017-07-25

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT00933335 2017-01-18

Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab

Phase 2 Completed

38 enrolled 36 charts

Lymphoma, Non-Hodgkin

NCT00950755 2017-01-18

Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology

Phase 2 Completed

41 enrolled 25 charts

Lymphoma, Non-Hodgkin

NCT00996996 2017-01-11

Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma

Phase 2 Completed

77 enrolled 34 charts

Lymphoma, Non-Hodgkin

NCT01663714 2017-01-11

Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.

Phase 2 Completed

30 enrolled 25 charts

Lymphoma, Non-Hodgkin

NCT00268983 2017-01-09

Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma

Phase 3 Completed

14 enrolled 20 charts

Lymphoma, Non-Hodgkin

NCT00938041 2017-01-09

Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 Antibody

Phase 2 Completed

32 enrolled 11 charts

Lymphoma, Non-Hodgkin

NCT01868035 2017-01-09

Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP

Phase 2 Completed

15 enrolled 18 charts

Lymphoma, Non-Hodgkin

NCT00989664 2016-12-13

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma

Phase 2 Completed

60 enrolled 26 charts

Lymphoma, Lymphoma, Non-Hodgkin

NCT01224821 2016-12-12

RIT-II-001

Phase 2 Completed

47 enrolled 22 charts

Lymphoma, Non-Hodgkin

NCT00996593 2016-11-23

Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab

Phase 2 Completed

43 enrolled 28 charts

Lymphoma, Non-Hodgkin

NCT00319332 2015-04-17

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Phase 3 Withdrawn

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00240565 2012-08-13

Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, Non-Hodgkin

NCT00062894 2007-09-17

Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab

Phase 1/2 Completed

Lymphoma, Non-Hodgkin

NCT00022880 2005-06-24

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00022893 2005-06-24

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT00022906 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT00022932 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT00022945 2005-06-24

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma

Phase 2 Completed

Lymphoma, Mantle-Cell

NCT00022958 2005-06-24

Expanded Access Study of Iodine-131 Anti-B1 Antibody

Phase NA Unknown

Lymphoma, Non-Hodgkin